Skip to Main Content

Paper Details

Efficacy and safety of elagolix with add-back therapy in women with uterine fibroids and coexisting adenomyosis.
F S Rep
9
2021
Elagolix, Participants, Patients, Uterine Fibroids, adenomyosis, elagolix, estradiol, fibroids, gonadotropin-releasing hormone, heavy menstrual, hot flushes, nausea, norethindrone acetate, uterine fibroids, women
Author NameAffiliation
David F ArcherEastern Virginia Medical School
Kurt T BarnhartPerleman School of Medicine at the University of Pennsylvania
  • 1 - 2

Datasets

Release 1.2